Astrana Health, Inc. announced it has successfully closed the acquisition of Prospect Health for a revised total purchase price of $708 million, down from the originally announced $745 million. The acquisition aims to enhance Astrana's capabilities in delivering high-quality and high-value care across the nation. The company expects Prospect Health to contribute approximately $1.2 billion in total revenue and $81 million in adjusted EBITDA annually. Astrana has updated its full-year 2025 guidance, projecting total revenue between $3.1 billion and $3.3 billion and adjusted EBITDA between $215 million and $225 million. The acquisition is expected to generate $12 million to $15 million in synergies over the next twelve to eighteen months. With this transaction, Astrana's net debt stands at $700 million, and the company is committed to reducing its net leverage ratio below 2.5x in the coming months.